Novo Holdings plans to invest about USD 35 bln by 2030Illustrative image – not actual.

Novo Holdings, the controlling shareholder of Novo Nordisk, plans to invest about USD 35 billion by 2030. Novo Holdings would invest about USD five billion a year in the next five years, and this could go up to USD seven billion a year by 2030.

Novo Holdings' portfolio comprises investments across life sciences and capital investments in equities, fixed-income assets, and real estate. Last week, it announced that it would buy key manufacturing subcontractor Catalent for USD 16.5 billion. The company is also investing in Indian private hospital chain Manipal Hospitals, as it seeks to tap into the growing market potential in Asia.

The company's future investments will be focused on countries in Asia, Europe, and North America. Novo Holdings has controlling stakes in industrial enzymes maker Novonesis, formerly known as Novozymes, and manages a portfolio of 160 companies.

← All latest storiesBack to top →